Sanford Burnham Prebys Medical Discovery Institute: Researchers Identify a Novel Player in Acute Myeloid Leukemia
September 14, 2021
September 14, 2021
LA JOLLA, California, Sept. 14 (TNSRes) -- Sanford Burnham Prebys Medical Discovery Institute issued the following news release:
A new study led by scientists at Sanford Burnham Prebys has shown that the protein RNF5 plays an unusual role in acute myeloid leukemia (AML). Unlike its expected role, marking aberrant proteins for destruction, RNF5 binds with a second cell protein called RBBP4 to control expression of genes implicated in AML. These findings, published in Nature Communica . . .
A new study led by scientists at Sanford Burnham Prebys has shown that the protein RNF5 plays an unusual role in acute myeloid leukemia (AML). Unlike its expected role, marking aberrant proteins for destruction, RNF5 binds with a second cell protein called RBBP4 to control expression of genes implicated in AML. These findings, published in Nature Communica . . .